{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:56:41Z","timestamp":1792198601983,"version":"4.4.0"},"reference-count":68,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2015,8,22]],"date-time":"2015-08-22T00:00:00Z","timestamp":1440201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["NeuroRehabilitation: An International, Interdisciplinary Journal"],"published-print":{"date-parts":[[2015,8,22]]},"abstract":"<jats:p>BACKGROUND: Fatigue is common in patients with Parkinson\u2019s disease (PD). It occurs at every stage of PD and affects quality of life. Fatigue severity worsens over time as PD progresses, and it is associated with other non-motor symptoms such as apathy, depression, sleep disorder, and cognitive dysfunction.<\/jats:p>\n                  <jats:p>PURPOSE: In this literature review, I discuss the measurement and pathophysiology of fatigue and fatigability. There are no evidence-based treatments for fatigue and fatigability available. I review several pilot studies on the effects of pharmacological agents and exercise on fatigue and fatigability. These studies provide some insights on the design of future larger clinical trials.<\/jats:p>\n                  <jats:p>CONCLUSION: Fatigue inventories including The Fatigue Severity Scale, the Multidimensional Fatigue Inventory, or theParkinson Fatigue Scale are used to assess the severity of fatigue. Finger tapping and force generation are useful in quantifying physical fatigability. A reaction time paradigm such as the Attention Network Test can be used to measure cognitive fatigability. Physical fatigability is associated with the change in cortical excitability in PD measured by Transcranial Magnetic Stimulation. Cognitive fatigability is most likely associated with the neurotransmitter abnormalities (dopaminergic, cholinergic and noradrenergic) in PD. Levodopa, modafanil, methylphenidate, and rasagiline may be effective in treating fatigue and fatigability. Exercise programs may also be effective.<\/jats:p>","DOI":"10.3233\/nre-151238","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T15:53:45Z","timestamp":1733414025000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":12,"title":["Fatigue in Parkinson\u2019s disease and potential interventions"],"prefix":"10.1177","volume":"37","author":[{"given":"Jau-Shin","family":"Lou","sequence":"first","affiliation":[{"name":"Dr. Roger Gilbertson Endowed Chair in Neurology, and Department of Neurology, University of North Dakota School of Medicine and Health Science and Sanford Health, Fargo, ND, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2015,8,22]]},"reference":[{"key":"r1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10390"},{"key":"r2","unstructured":"AlvesGWentzel-LarsenTLarsenJP2004Is fatigue an independent and persistent symptom in patients with Parkinson\u2019s disease?6319081911"},{"key":"r3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92413-4"},{"key":"r4","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22643"},{"key":"r5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02900.x"},{"key":"r6","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(99)00041-7"},{"key":"r7","unstructured":"Brasil-Neto, J. P., Cohen, L. G., Hallett, M. Central fatigue as revealed by post-exercise decrement of motor evoked potentialsMuscle Nerve17713719"},{"key":"r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2004.07.007"},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg033"},{"key":"r10","doi-asserted-by":"publisher","DOI":"10.1177\/0269215511432652"},{"key":"r11","doi-asserted-by":"publisher","DOI":"10.1038\/nrn755"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/312426"},{"key":"r13","doi-asserted-by":"publisher","DOI":"10.3233\/NRE-141162"},{"key":"r14","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.1.20"},{"key":"r15","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26058"},{"key":"r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2012.01.024"},{"key":"r17","doi-asserted-by":"publisher","DOI":"10.1212\/01.CPJ.0000436213.11132.8e"},{"key":"r18","unstructured":"FahnSOakesDShoulsonI2004Levodopa and the progression of Parkinson\u2019s diseaseNEngl J Med5124982508"},{"key":"r19","doi-asserted-by":"publisher","DOI":"10.1162\/089892902317361886"},{"key":"r20","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22989"},{"key":"r21","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1201"},{"key":"r22","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21198"},{"key":"r23","unstructured":"GoldmanJGStebbinsGTLeungVTilleyBCGoetzCG2014Relationships among cognitive impairment, sleep, and fatigue in Parkinson\u2019s disease using the MDS-UPDRS. PMIDParkinsonism Relat Disord25150770"},{"key":"r24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03663.x"},{"key":"r25","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01277.2013"},{"key":"r26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31827f07be"},{"key":"r27","unstructured":"KlugerBMParraVJacobsonCGarvanCWRodriguezRLFernandezHHFogelASkoblarBMBowersDOkunMS2012The prevalence of fatigue following deep brain stimulation surgery in Parkinson\u2019s disease and association with quality of lifeParkinsons Dis769506"},{"key":"r28","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520460115022"},{"key":"r29","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00740-9"},{"key":"r30","unstructured":"LongoDFauciASKasperDL2011Harrison\u2019s principles of internal medicine18th EdMcGraw-Hill Medical"},{"key":"r31","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1042"},{"key":"r32","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000042781.22278.0A"},{"key":"r33","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10505"},{"key":"r34","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-2457(03)00040-3"},{"key":"r35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmr.2005.08.012"},{"key":"r36","unstructured":"LouJSDimitrovaDMArnoldGC2008Exacerbated objective mental fatigue in PD(S1)S96"},{"key":"r37","unstructured":"LouJSDimitrovaDParkBArnoldGBeldingHNuttJ2009aCortical excitability in PD: A 18-month longitudinal study. S:SAnn Neurol6651"},{"key":"r38","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181aa916a"},{"key":"r39","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200926030-00002"},{"key":"r40","unstructured":"LouJSDimitrovaKAChungKAAndreaSBNuttJ2013The effects of Rivastigmine and atomoxetine innon-demented Parkinson\u2019s diseaseMovement DisordersS1S191"},{"key":"r41","unstructured":"LouJSDimitrovaSBMurchisonCArnoldGOkenBNuttJ2014The Effect of levodopa dose on attention andvigilance in non-demented patients with Parkinson\u2019s diseaseMovement Disorders29S1S191"},{"key":"r42","unstructured":"MarroccoRTDavidsonMC1998Neumistry of attentionParasuramanRThe Attentive Brain3550MassMIT, Cambridge"},{"key":"r43","unstructured":"Mendonca, D. A., Menezes, K. & Jog, M. S. (Oct). Methylphenidate improves fatigue scores in Parkinson\u2019s disease: A randomized controlled trialMov Disord221420702076"},{"key":"r44","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.07.010"},{"key":"r45","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2006.01.017"},{"key":"r46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809335"},{"key":"r47","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.065870"},{"key":"r48","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.5.413"},{"key":"r49","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00164.2004"},{"key":"r50","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-062111-150525"},{"key":"r51","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.13.030190.000325"},{"key":"r52","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh445"},{"key":"r53","unstructured":"RothwellJCHallettMBerardelliA1999Magnetic stimulation: motor evoked potentialsElectroencep and Clin Neurophy. In: (eds) G. Deuschl and A Eisen, Recommendations for the Practice of Clinical Neurophysiology: Guidelines of the International Federation of Clinical Neurophvsiologysuppl 5297104"},{"key":"r54","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(83)90993-9"},{"key":"r55","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000324862.29733.69"},{"key":"r56","unstructured":"ShulmanLMTabackRRabinsteinAANon-recognition of depression and other non-motorsymptoms in Parkinson\u2019s diseaseParkinsonism Relat Disord193197"},{"key":"r57","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12282"},{"key":"r58","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(94)00125-O"},{"key":"r59","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000587"},{"key":"r60","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12205"},{"key":"r61","unstructured":"UcEYDoerschugKMehtaS2008Cardiovascular fitness and cognition in mild-moderateParkinson\u2019s diseaseNeurology70A290"},{"key":"r62","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000644"},{"key":"r63","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-140446"},{"key":"r64","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0270(97)02251-6"},{"key":"r65","doi-asserted-by":"crossref","unstructured":"WangCDingMKlugerBM2014Change in intraindividual variability over time as a key metric fordefining performance-based cognitive fatigability{251258","DOI":"10.1016\/j.bandc.2014.01.004"},{"key":"r66","unstructured":"Williams-GrayCHFoltynieTLewisSJBarkerRA2006Cognitive deficits and psychosis in Parkinson_s disease:a review of pathophysiology and therapeutic optionsCNSDrugs20477505"},{"key":"r67","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23966"},{"key":"r68","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181ea1597"}],"container-title":["NeuroRehabilitation: An International, Interdisciplinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/NRE-151238","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/NRE-151238","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/NRE-151238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:48:13Z","timestamp":1777614493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/NRE-151238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,22]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8,22]]}},"alternative-id":["10.3233\/NRE-151238"],"URL":"https:\/\/doi.org\/10.3233\/nre-151238","relation":{},"ISSN":["1053-8135","1878-6448"],"issn-type":[{"value":"1053-8135","type":"print"},{"value":"1878-6448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,22]]}}}